Drugs / Custodiol cardioplegia
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05221294 | Feb 2022 → Nov 2023 | — | Fayoum University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Custodiol cardioplegia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05221294 ↗ |
| Known as | histidine- tryptophan- ketoglutarate | “Custodiol (histidine- tryptophan- ketoglutarate) solution has been described in the 1970s by Bretschneider” NCT05221294 ↗ |